The Sybil Lung Cancer Consortium Mission
The current state of lung cancer screening in the U.S. has failed patients in both reach and grasp: we are not screening all high-risk patients nor are we providing appropriate screening and follow-up to those who qualify.
The foundation of this consortium rests on three principles:
- No one deserves lung cancer
- Anyone with lungs can get lung cancer
- Screening high risk people for lung cancer improves outcomes.
These three principles are united under implementation science, with the goal of studying how best to deploy Sybil in the real world, in a way that can be replicated in diverse health care settings.
We believe the foundational work we are conducting as a consortium will transform and elevate Sybil from its current state as a validated risk classifier to a useable, practical, clinical tool that can dramatically improve early lung cancer detection. The work of the consortium will form the pillars of a lung screening system, which will provide simplified and equitable access to screening.
